Deep cutaneous mycoses in kidney transplant recipients: diagnostic and therapeutic challenges.

cutaneous mycoses phaeohyphomycosis subcutaneous transplant recipients

Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
16 Jan 2024
Historique:
medline: 17 1 2024
pubmed: 17 1 2024
entrez: 16 1 2024
Statut: aheadofprint

Résumé

Deep cutaneous mycoses (DCMs) are rare infections that extend throughout the dermis and subcutis, often occurring after inoculation with pathogenic fungi. Trends toward a growing incidence have been observed that may be partially related to an increasing population of solid organ transplant patients. The aim of this study is to describe the diagnostic and the outcomes of DCM among kidney transplant recipients so as to optimize their management. We performed a retrospective review of cases of DCM occurring among kidney transplant recipients in our institution over 12 years. Twenty cases were included. Lesions were only located on the limbs and presented mainly as single (10/20, 50%) nodular lesions (15/20, 75%), with a mean size of 3 cm. Direct mycological examination was positive for 17 patients (17/20, 85%) and the cultures were consistently positive. Thirteen different fungal species were observed including phaehyphomycetes (n = 8), hyalohyphomycetes (n = 3), dermatophyte (n = 1), and mucorale (n = 1). The (1-3) beta-D-glucan antigen (BDG) was also consistently detected in the serum (20/20, 100%). Systematic imaging did not reveal any distant infectious lesions, but locoregional extension was present in 11 patients (11/14, 79%). Nineteen patients received antifungal treatment (19/20, 95%) for a median duration of three months, with surgery for 10 (10/20, 50%). There is a great diversity of fungal species responsible for DCMs in kidney transplant recipients. The mycological documentation is necessary to adapt the antifungal treatment according to the sensitivity of the species. Serum BDG positivity is a potentially reliable and useful tool for diagnosis and follow-up. A great diversity of fungal species are responsible for deep cutaneous mycoses in kidney transplant recipients. Serum BDG positivity is a potentially reliable and useful tool for diagnosis and follow-up.

Autres résumés

Type: plain-language-summary (eng)
A great diversity of fungal species are responsible for deep cutaneous mycoses in kidney transplant recipients. Serum BDG positivity is a potentially reliable and useful tool for diagnosis and follow-up.

Identifiants

pubmed: 38228404
pii: 7560553
doi: 10.1093/mmy/myae001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Chloé Bertin (C)

Unité de Parasitologie-Mycologie, Service de Microbiologie clinique, GHU Necker-Enfants-Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Emilie Sitterlé (E)

Unité de Parasitologie-Mycologie, Service de Microbiologie clinique, GHU Necker-Enfants-Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Anne Scemla (A)

Service de Néphrologie-Transplantation, GHU Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Sylvie Fraitag (S)

Service d'Anatomo-pathologie, GHU Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Sarah Delliere (S)

Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, F-75015 Paris, France, Université de Paris, Paris, France.
Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.

Sarah Guegan (S)

Service de Dermatologie, GHU Cochin, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Dea Garcia Hermoso (DG)

Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, F-75015 Paris, France, Université de Paris, Paris, France.

Stéphanie Leclerc-Mercier (S)

Service de Dermatologie, GHU Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Claire Rouzaud (C)

Service de Maladies Infectieuses, GHU Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Fanny Lanternier (F)

Institut Pasteur, Université Paris Cité, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, F-75015 Paris, France, Université de Paris, Paris, France.
Service de Maladies Infectieuses, GHU Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.

Marie-Elisabeth Bougnoux (ME)

Unité de Parasitologie-Mycologie, Service de Microbiologie clinique, GHU Necker-Enfants-Malades, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
Institut Pasteur, Université Paris Cité, INRAE, USC2019, Unité Biologie et Pathogénicité Fongiques, F-75015 Paris, France.

Classifications MeSH